Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy

BACKGROUND: In bladder and breast cancer, the claudin-low subtype is widely identified, revealing a distinct tumor microenvironment (TME) and immunological feature. Although we have previously identified individual claudin members as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC),...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cuijian, Li, Yifan, Qian, Jinqin, Zhu, Zhenpeng, Huang, Cong, He, Zhisong, Zhou, Liqun, Gong, Yanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719924/
https://www.ncbi.nlm.nih.gov/pubmed/36479115
http://dx.doi.org/10.3389/fimmu.2022.1020729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719924/
https://www.ncbi.nlm.nih.gov/pubmed/36479115
http://dx.doi.org/10.3389/fimmu.2022.1020729

Ejemplares similares